Explore 3 Stock Ideas & Industry Insights Download Free Report

888-969-2592
Shopping Cart 0
countryflagCA
Login

Home CompaniesTristel

Tristel

Healthcare Medical Instruments & Supplies
PortfolioPortfolio WatchlistWatchlist
Company price
407.5 GBX 0.00(0%)
Last update at 2026-10-27T17:10:00Z
VOLUME
183675
Market Cap
182.14M
P/E
23.75

Momentum Score

…

Tristel plc develops, manufactures, and sells infection prevention products in the United Kingdom, Australia, Germany, Western Europe, and internationally. The company operates through three segments: Hospital Medical Device Decontamination, Hospital Environmental Surface Disinfection, and Other. It offers device decontamination products, including wipes system, ULT, OPH, Stella system, fuse for Stella, rinse assure, clean, EVE, medistel, EVA system, daisygrip, fuse for surfaces, dosing system, airstel, enzystel, DOK, pre-clean wipes, rinse wipes, sporicidal wipes, clean for Stella, protect, and wipes; surface disinfection products, such as FUSE, JET, JET LUX, JET PRO, TANK 10 CLO2, TANK 5 CLO2, and TILT 5 CLO2; as well as operates 3T, a cloud-based platform alternative to paper-based traceability systems. The company provides its medical disinfection products, including airway management, cardiology, ear, nose and throat, endoscopy, gastrointestinal physiology, laboratory, ophthalmology, phlebotomy, reproductive health/IVF, surface, ultrasound, urology, women's health, and other products under the Tristel brand. Tristel plc was founded in 1993 and is headquartered in Snailwell, the United Kingdom.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
400.00
Low
415.00
High
52 Week Price Range
293.42
Low
438.48
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High

Key Metrics*

Previous Close
407.50
Dividend Yield
3.76%
Revenue TTM
49.54M
Revenue Per Share
1.04
Gross Profit TTM
40.45M
Debt / Equity
0.18
ROE
24.19%
Net Debt
-2.77M
ROCE
22.79%
Diluted EPS TTM
0.16

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Type yearly yearly yearly yearly yearly
Date 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Income before tax 8.42M 7.08M 5.11M 1.50M 3.76M
Minority interest - - - - 0.01M
Net income 6.64M 6.49M 4.46M 0.93M 2.97M
Selling general administrative 24.97M 22.79M 19.90M 17.32M 16.38M
Selling and marketing expenses 0.34M 0.33M 0.32M - -
Gross profit 37.94M 33.58M 29.18M 24.66M 24.74M
Reconciled depreciation 2.80M 2.71M 2.55M 2.71M 2.75M
Ebit 8.68M 7.30M 5.36M 4.20M 4.76M
Ebitda 11.47M 10.01M 7.91M 6.91M 7.58M
Depreciation and amortization 2.80M 2.71M 2.55M 2.71M 2.81M
Operating income 8.40M 6.98M 5.28M 4.20M 4.76M
Other operating expenses 38.06M 34.95M 30.73M 27.00M 26.24M
Interest expense 0.26M 0.22M 0.18M 0.20M 0.20M
Tax provision 1.78M 0.59M 0.65M 0.57M 0.79M
Interest income 0.28M 0.32M 0.01M 0.00M 0.00M
Net interest income 0.02M 0.10M -0.17M -0.19M -0.19M
Income tax expense 1.78M 0.59M 0.65M 0.57M 0.79M
Total revenue 46.46M 41.93M 36.01M 31.12M 31.00M
Total operating expenses 29.54M 26.60M 23.89M 20.53M 19.98M
Cost of revenue 8.52M 8.36M 6.83M 6.46M 6.25M
Total other income expense net 0.02M 0.10M -0.17M -2.70M -1.00M
Net income from continuing ops 6.64M 6.49M 4.46M 0.93M 2.97M
Net income applicable to common shares - - 4.46M 0.93M 2.97M
Breakdown 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Type yearly yearly yearly yearly yearly
Date 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Total assets 45.33M 44.11M 41.37M 38.74M 39.93M
Intangible assets 5.02M 4.88M 4.76M 4.14M 6.70M
Other current assets 1.63M 2.37M 0.00M 6.56M 5.25M
Total liab 12.34M 11.70M 10.68M 9.75M 9.85M
Total stockholder equity 32.99M 32.41M 30.68M 28.98M 30.08M
Deferred long term liab - - 1.89M 1.42M 1.57M
Other current liab 2.13M 2.91M 0.10M 2.17M -0.17M
Common stock 0.48M 0.48M 0.47M 0.47M 0.47M
Capital stock 0.48M 0.48M 0.47M 0.47M 0.47M
Retained earnings 15.80M 15.44M 14.09M 12.37M 14.00M
Other liab - - 0.60M 0.72M 0.64M
Good will 4.97M 5.00M 5.16M 5.24M 5.26M
Other assets - - 3.17M 1.49M 1.80M
Cash 8.64M 6.14M 7.11M 8.88M 8.09M
Total current liabilities 7.26M 6.59M 5.76M 4.04M 3.94M
Net debt -2.77M -0.28M -1.93M -3.07M -2.19M
Short term debt 2.28M 1.03M 0.86M 0.81M 0.63M
Short long term debt total 5.88M 5.86M 5.18M 5.81M 5.91M
Other stockholder equity 15.31M 16.49M 16.11M 16.14M 15.60M
Property plant equipment - - 7.83M 8.00M 8.54M
Total current assets 26.18M 24.71M 22.34M 19.87M 17.61M
Net tangible assets - - 22.65M 19.60M 18.11M
Short term investments 4.20M 5.65M 2.43M - -
Net receivables 7.06M 5.87M 8.23M 6.56M 5.25M
Inventory 4.64M 4.68M 4.57M 4.42M 4.27M
Accounts payable 1.59M 1.72M 4.80M 3.22M 3.48M
Accumulated other comprehensive income 1.41M -0.65M - - -
Non current assets total 19.16M 19.40M 19.03M 18.87M 22.32M
Capital lease obligations 5.88M 5.86M 5.18M 5.81M 5.91M
Breakdown 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Type yearly yearly yearly yearly yearly
Date 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Investments 1.45M -5.08M -4.84M -1.20M -1.77M
Change to liabilities - - 1.33M -0.25M -1.20M
Total cashflows from investing activities -0.25M -5.08M -4.84M -1.20M -1.77M
Net borrowings - - -1.13M -0.93M -0.80M
Total cash from financing activities -7.30M -6.57M -5.44M -3.62M -2.83M
Net income 8.42M 6.49M 5.11M 1.50M 3.76M
Change in cash 2.50M -0.97M -1.77M 0.79M 1.88M
Begin period cash flow 6.14M 7.11M 8.88M 8.09M 6.21M
End period cash flow 8.64M 6.14M 7.11M 8.88M 8.09M
Total cash from operating activities 10.32M 10.89M 8.49M 5.55M 6.48M
Issuance of capital stock 0.38M 0.68M 0.19M 0.40M 0.98M
Depreciation 2.80M 2.71M 2.55M 2.71M 2.75M
Other cashflows from investing activities -0.85M -0.73M 0.01M 0.00M 0.00M
Dividends paid 6.66M 6.22M 4.51M 3.09M 3.02M
Change to inventory 0.04M -0.11M -0.15M -0.15M 0.35M
Change to account receivables -0.94M -0.28M -1.23M -0.60M 1.17M
Sale purchase of stock - - - - 0.98M
Other cashflows from financing activities - -1.02M -1.13M -0.93M -0.80M
Change to netincome - - 1.53M 2.92M 0.44M
Capital expenditures 0.86M 1.14M 2.42M 1.20M 1.77M
Change in working capital -0.16M -0.56M -0.05M -1.00M 0.32M
Stock based compensation 0.37M 1.09M 1.06M 0.60M 0.82M
Other non cash items -1.11M 2.25M 0.17M 1.75M 0.19M
Free cash flow 9.46M 10.06M 6.07M 4.35M 4.71M

Peer Comparison*

Sector: Healthcare Industry: Medical Instruments & Supplies

Stock Name
Change
(GBX)
Price
(GBX)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
TSTL
Tristel		 -
-%		 407.50 23.75 19.08 3.68 5.29 3.43 13.18
CTEC
ConvaTec Group PLC		 -4.20
1.71%		 240.80 37.27 14.66 1.79 3.77 2.94 13.89
AMS
Advanced Medical Solutions Group plc		 1.00
0.35%		 283.00 40.60 16.84 1.92 1.66 2.16 11.16
SPEC
Inspecs Group plc		 -3.00
3.33%		 87.00 - 16.16 0.43 0.95 0.62 7.94
BVC
Batm Advanced Communications Ltd		 -0.25
2.16%		 11.30 - 39.53 0.36 0.90 0.37 2.44

Profile*

Tristel

Tristel plc develops, manufactures, and sells infection prevention products in the United Kingdom, Australia, Germany, Western Europe, and internationally. The company operates through three segments: Hospital Medical Device Decontamination, Hospital Environmental Surface Disinfection, and Other. It offers device decontamination products, including wipes system, ULT, OPH, Stella system, fuse for Stella, rinse assure, clean, EVE, medistel, EVA system, daisygrip, fuse for surfaces, dosing system, airstel, enzystel, DOK, pre-clean wipes, rinse wipes, sporicidal wipes, clean for Stella, protect, and wipes; surface disinfection products, such as FUSE, JET, JET LUX, JET PRO, TANK 10 CLO2, TANK 5 CLO2, and TILT 5 CLO2; as well as operates 3T, a cloud-based platform alternative to paper-based traceability systems. The company provides its medical disinfection products, including airway management, cardiology, ear, nose and throat, endoscopy, gastrointestinal physiology, laboratory, ophthalmology, phlebotomy, reproductive health/IVF, surface, ultrasound, urology, women's health, and other products under the Tristel brand. Tristel plc was founded in 1993 and is headquartered in Snailwell, the United Kingdom.

Lynx Business Park, Snailwell, United Kingdom, CB8 7NY

44 16 3872 1500

https://tristel.com

270

Name Title Year Born
Mr. Paul C. Swinney CEO & Exec. Director 1959
Ms. Elizabeth A. Dixon CFO & Exec. Director 1970
Mr. Bart Victor Margaretha Leemans Exec. Director 1964
Ms. Heidi A. Allard UK Fin. Director, Global Financial Controller & Company Sec. NA
Mr. Matthew Giovanni Sassone CEO & Director 1975
Ms. Anna Katarzyna Wasyl Chief Financial Officer & Director 1980
Emily Davey Global Marketing Director NA
Aimee Scarbrow Human Resources Director NA
Julija Shabanova Executive Director NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

ITH
CAD 2.15
+27.68%
HG
CAD 4.11
+19.13%
PPTA
CAD 27.74
+17.99%
UCU
CAD 2.10
+17.32%
GAU
CAD 3.49
+16.72%
TSU
CAD 29.67
-29.71%
PXT
CAD 19.73
-16.91%
LAS-A
CAD 230.50
-9.25%
IFP
CAD 13.50
-8.35%
NFI
CAD 24.01
-7.80%

Equity Sectors*

  • Basic Materials

    +3.74%

  • Communication Services

    +0.56%

  • Consumer Cyclical

    -0.34%

  • Consumer Defensive

    +0.11%

  • Energy

    +1.33%

  • Financial Services

    -0.26%

  • Healthcare

    +2.54%

  • Industrials

    -0.11%

  • Real Estate

    -0.23%

  • Technology

    +1.91%

  • Utilities

    +1.05%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Support

Hi! How can we help you today?

Loading…